Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.
2.

Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.

Taylor DM, Wright T, Libretto SE; Risperidone Olanzapine Drug Outcomes Studies in Schizophrenia (RODOS) U.K. Investigator Group.

J Clin Psychiatry. 2003 May;64(5):589-97.

PMID:
12755664
3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

Comparison of cost, dosage and clinical preference for risperidone and olanzapine.

Rabinowitz J, Lichtenberg P, Kaplan Z.

Schizophr Res. 2000 Dec 15;46(2-3):91-6.

PMID:
11120420
5.

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

Kelly DL, Nelson MW, Love RC, Yu Y, Conley RR.

Psychiatr Serv. 2001 May;52(5):676-8.

PMID:
11331805
6.
7.

Cost evaluation of risperidone compared with olanzapine.

Byerly MJ, Weber M, Brooks D, Casey SB, Elliot S, Hawkins J.

Psychiatr Serv. 2003 May;54(5):742-4.

PMID:
12719509
8.

Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.

Gureje O, Miles W, Keks N, Grainger D, Lambert T, McGrath J, Tran P, Catts S, Fraser A, Hustig H, Andersen S, Crawford AM.

Schizophr Res. 2003 Jun 1;61(2-3):303-14.

PMID:
12729882
9.

Olanzapine and risperidone.

Love RC, Kelly DL.

Am J Health Syst Pharm. 2003 Mar 1;60(5):487-8; author reply 488-9. No abstract available.

PMID:
12635459
10.
11.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
12.

Economic evaluations of olanzapine and risperidone.

Shaw JW.

Am J Health Syst Pharm. 2002 Jul 15;59(14):1366-75. Review. No abstract available.

PMID:
12132564
13.

A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder.

Conley RR, Mahmoud R.

Am J Psychiatry. 2001 May;158(5):765-74. Erratum in: Am J Psychiatry 2001 Oct;158(10):1759.

PMID:
11329400
14.

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C Jr, Tollefson GD.

J Clin Psychopharmacol. 1997 Oct;17(5):407-18.

PMID:
9315992
15.

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

Tunis SL, Faries DE, Nyhuis AW, Kinon BJ, Ascher-Svanum H, Aquila R.

Value Health. 2006 Mar-Apr;9(2):77-89.

16.

Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.

Kinon BJ, Basson BR, Gilmore JA, Malcolm S, Stauffer VL.

J Clin Psychiatry. 2000 Nov;61(11):833-40.

PMID:
11105736
17.

Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.

Edgell ET, Andersen SW, Johnstone BM, Dulisse B, Revicki D, Breier A.

Pharmacoeconomics. 2000 Dec;18(6):567-79.

PMID:
11227395
18.
19.

Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.

Rascati KL, Johnsrud MT, Crismon ML, Lage MJ, Barber BL.

Pharmacoeconomics. 2003;21(10):683-97.

PMID:
12828491
20.

Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.

Bokszanska A, Martin G, Vanstraelen M, Holt G, Bouras N, Taylor D.

Int Clin Psychopharmacol. 2003 Sep;18(5):285-91.

PMID:
12920389

Supplemental Content

Support Center